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Stem cells in nerve reconstruction: 
Hype, hope or reality?
1. Commercially available nerve graft substitutes have good outcomes 
in mixed/motor nerves in gaps less than 6 mm and internal diameters 
between 3 and 7 mm. (this thesis)
2. Seeding of undifferentiated adipose-derived mesenchymal stromal 
cells onto processed nerve allografts permits the secretion of neuro-
trophic and angiogenic factors in-vitro. (this thesis)
3. Mesenchymal stromal cells seeded onto decellularized nerve allografts 
have a finite survival in vivo. (this thesis)
4. Mesenchymal stromal cells have a beneficial effect on angiogenesis. 
(this thesis)
5.  Implanted mesenchymal stromal cells do not differentiate into 
schwann cell like cells. (this thesis)
6. The concept of combining decellularized nerve with mesenchymal stro-
mal cells is not novel. (NIH reviewer)
7. A ready available nerve graft alternative is needed. (Alexander A. Shin, 
2015)
8. Sponsorship of drug and device studies by the manufacturing company 
leads to more favorable efficacy results and conclusions than sponsor-
ship by other sources. (Lundh A, Cochrane Database Syst Rev. 2017 Feb 
16;2:MR000033) 
9. Processed nerve allografts can be used to bridge nerve gaps cre-
ated by resection of neuromas. (Dumanian GA, Foot Ankle Int. 2016 
Oct;37(10):1098-1105. Epub 2016 Jun 23) 
10.  Primary basal cell carcinomas are more often completely excised by 
dermatologists than by general practitioners and plastic surgeons. (van 
den Bos, Dermatology. 2018 Sep; 234(3-4): 86–91)
11. If you can find a path with no obstacles, it probably doesn’t lead any-
where. (Frank Clark, 1860–1960) 
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